全文获取类型
收费全文 | 261336篇 |
免费 | 26533篇 |
国内免费 | 18399篇 |
专业分类
耳鼻咽喉 | 2434篇 |
儿科学 | 2750篇 |
妇产科学 | 3325篇 |
基础医学 | 28911篇 |
口腔科学 | 4981篇 |
临床医学 | 35572篇 |
内科学 | 35674篇 |
皮肤病学 | 2685篇 |
神经病学 | 13945篇 |
特种医学 | 10235篇 |
外国民族医学 | 164篇 |
外科学 | 26107篇 |
综合类 | 47622篇 |
一般理论 | 25篇 |
预防医学 | 17040篇 |
眼科学 | 7754篇 |
药学 | 28502篇 |
229篇 | |
中国医学 | 16681篇 |
肿瘤学 | 21632篇 |
出版年
2024年 | 282篇 |
2023年 | 3953篇 |
2022年 | 6676篇 |
2021年 | 12060篇 |
2020年 | 11070篇 |
2019年 | 8783篇 |
2018年 | 8664篇 |
2017年 | 8928篇 |
2016年 | 7176篇 |
2015年 | 12148篇 |
2014年 | 15722篇 |
2013年 | 13998篇 |
2012年 | 20827篇 |
2011年 | 22993篇 |
2010年 | 14796篇 |
2009年 | 11785篇 |
2008年 | 15032篇 |
2007年 | 14580篇 |
2006年 | 14309篇 |
2005年 | 13801篇 |
2004年 | 8599篇 |
2003年 | 7911篇 |
2002年 | 6443篇 |
2001年 | 5673篇 |
2000年 | 6019篇 |
1999年 | 6126篇 |
1998年 | 3707篇 |
1997年 | 3647篇 |
1996年 | 2937篇 |
1995年 | 2765篇 |
1994年 | 2262篇 |
1993年 | 1475篇 |
1992年 | 1979篇 |
1991年 | 1662篇 |
1990年 | 1366篇 |
1989年 | 1140篇 |
1988年 | 1051篇 |
1987年 | 886篇 |
1986年 | 744篇 |
1985年 | 544篇 |
1984年 | 332篇 |
1983年 | 241篇 |
1982年 | 142篇 |
1981年 | 143篇 |
1980年 | 113篇 |
1979年 | 147篇 |
1978年 | 51篇 |
1977年 | 54篇 |
1975年 | 60篇 |
1974年 | 58篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
2.
3.
4.
5.
6.
Lei Qi Mingxing Wang Yuehui Jia Yuanyuan Wang Liangfang Xue Linlin Du Shuxiu Hao Shengqi Su Ruixiang Wang Huixin Sun Chen Feng Guijin Li Qingyu Zeng Cunqi Lv Jiacheng Li Qi Li Yunyan Zhang Tong Wang 《International journal of cancer. Journal international du cancer》2023,153(6):1172-1181
Information regarding the impact of the coronavirus disease 2019 (COVID-19) pandemic on cervical cancer in mainland China is lacking. We explored its impact on the hospital attendance of patients with primary cervical cancer. We included 1918 patients with primary cervical cancer who initially attended Harbin Medical University Cancer Hospital between January 23, 2019, and January 23, 2021. Attendance decreased by 31%, from 1135 in 2019 to 783 in 2020, mainly from January to June (𝜒2 = 73.362, P < .001). The percentage of patients detected by screening decreased from 12.1% in January-June 2019 to 5.8% in January-June 2020 (𝜒2 = 7.187, P = .007). Patients with stage I accounted for 28.4% in 2020 significantly lower than 36.6% in 2019 (𝜒2 = 14.085, P < .001), and patients with stage III accounted for 27.1% in 2020 significantly higher than 20.5% in 2019 (𝜒2 = 11.145, P < .001). Waiting time for treatment was extended from 8 days (median) in January-June and July-December 2019 to 16 days in January-June (𝜒2 = 74.674, P < .001) and 12 days in July-December 2020 (𝜒2 = 37.916, P < .001). Of the 179 patients who delayed treatment, 164 (91.6%) were for the reasons of the healthcare providers. Compared to 2019, the number of patients in Harbin or non-Harbin in Heilongjiang Province and outside the province decreased, and cross-regional medical treatment has been hindered. The COVID-19 pandemic has negatively impacted cervical cancer patient attendance at the initial phase. These results are solid evidence that a strategy and mechanism for the effective attendance of cervical cancer patients in response to public health emergencies is urgently needed. 相似文献
7.
8.
Xi Tian Yue Wang Wenhao Xu Haidan Tang Shuxuan Zhu Aihetaimujiang Anwaier Wangrui Liu Wenfeng Wang Wenkai Zhu Jiaqi Su Yuanyuan Qu Hailiang Zhang Dingwei Ye 《International journal of cancer. Journal international du cancer》2023,152(1):66-78
In clear cell renal cell carcinoma (ccRCC), glycolysis is enhanced mainly because of the increased expression of key enzymes in glycolysis. Hence, the discovery of new molecular biomarkers for glycolysis may help guide and establish a precise system of diagnosis and treatment for ccRCC. Expression profiles of 1079 tumor samples of ccRCC patients (including 311 patients treated with everolimus or nivolumab) were downloaded from public databases. Proteomic profiles of 232 ccRCC samples were obtained from Fudan University Shanghai Cancer Center (FUSCC). Biological changes, tumor microenvironment and prognostic differences were explored between samples with various glycolysis characteristics. There were significant differences in CD8+ effector T cells, epithelial-to-mesenchymal transition and pan-fibroblast TGFb between the Low and High glyScore groups. The tumor mutation burden of the Low glyScore group was lower than that of the High glyScore group. And higher glyScore was significantly associated with worse overall survival (OS) in 768 ccRCC patients (P < .0001). External validation in FUSCC cohort also indicated that glyScore was of strong ability for predicting OS (P < .05). GlyScore may serve as a biomarker for predicting everolimus response in ccRCC patients due to its significant associations with progression-free survival (PFS). And glyScore may also predict overall survival in patients treated with nivolumab. We calculated the glyScore in ccRCC and the defined glyScore was of strong ability for predicting OS. In addition, glyScore may also serve as a biomarker for predicting PFS in patients treated with everolimus and could predict OS in patients treated with nivolumab. 相似文献
9.
目的:应用PDCA循环优化医院新冠病毒核酸检测的流程,提升核酸检测能力,以满足疫情防控和临床患者的需求。方法:应用PDCA循环,分析核酸检测流程存在的问题,建立标准化的核酸检测体系。同时,收集2020年10月至12月(优化前)和2021年10月至12月(优化后)的数据,采用SPSS 22.0软件进行统计分析,以评价PDCA循环的优化效果。结果:经过PDCA循环优化后,总检测中位标本数从20 307个增加至71 403个,优化前后差异有统计学意义(P=0.018)。中位送检时间从224分钟缩短至208分钟,中位检测时间从234分钟缩短至151分钟,中位报告时间从461分钟缩短至371分钟,优化前后差异均有统计学意义(P < 0.001)。结论:应用PDCA循环,能够制定并持续完善标准化的核酸检测流程,有助于提高核酸检测能力和服务水平。 相似文献
10.